Biodesix, Inc. Jobs and Profile

Biodesix is a pioneer in enabling personalized medicine using mass spectrometry-based molecular diagnostics to rapidly analyze protein content in biological samples. Biodesix uses its proprietary ProTS^® Platform technology to rapidly discover, validate and commercialize tests for physicians to improve patient outcomes. Led by theoretical physicist Dr. Heinrich Roder and his team of world-class scientists, the ProTS breakthrough technology has been developed over the past seven years. In addition to Dr. Roder, the company's management team includes David Brunel, a successful serial entrepreneur, and several successful industry veterans in the pharmaceutical and diagnostic business.

Biodesix, using its research platform, is developing diagnostic products for the non-invasive early detection of disease, for the stratification of patient populations to improve treatment (distinguishing between patients who are likely to benefit from a particular treatment from those who may not), and for the provision of technically simple means for continuous disease monitoring.